Home
>
US Stocks
>
Werewolf Therapeutics Inc
Werewolf Therapeutics Inc
HOWL

Werewolf Therapeutics Inc

$16.810.94%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
16.55
Today Low/High
16.34 / 16.91
52 Week Low/High
$11.23 / $23.99
Market Cap
$401.66M

Company Details

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is leveraging its proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Its most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors.The company is continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.
Organisation
Werewolf Therapeutics Inc
Employees
28

Discover more

Frequently Asked Questions

What is Werewolf Therapeutics Inc share price today

Can Indians buy Werewolf Therapeutics Inc shares?

How can I buy Werewolf Therapeutics Inc shares from India?

Can Fractional shares of Werewolf Therapeutics Inc be purchased?

What are the documents required to start investing in Werewolf Therapeutics Inc stocks?

We are a SEBI registered investement advisor